Leslie M. Randall
0000-0003-3790-4858
Publication & Citation Trends
Publications
0 total
ABSTRACTS OF THE 15th INTERNATIONAL CHARITÉ MAYO CONFERENCE ON “GLOBAL PERSPECTIVES AND FUTURE DIRECTIONS IN WOMEN’S CANCER”
Cited by 0
Semantic Scholar
Pembrolizumab or Placebo With Chemoradiotherapy Followed by Pembrolizumab or Placebo for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): Overall Survival Results From a Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial
Cited by 0
Semantic Scholar
Top advances of the year: Cervical cancer OA
Cited by 19
Semantic Scholar
Progress in the treatment paradigms for locally advanced cervical cancer.
Cited by 2
Semantic Scholar
#168 UPLIFT (ENGOT-Ov67/GOG-3048): results from the phase 2 trial of upifitamab rilsodotin (UpRi; XMT-1536), a NaPi2b-directed dolaflexin antibody-drug conjugate (ADC) in platinum-resistant ovarian cancer (PROC)
Cited by 2
Semantic Scholar
285 Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-Cx11/GOG 3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in patients with high-risk locally advanced cervical cancer
Cited by 1
Semantic Scholar
Research Topics
Ovarian cancer diagnosis and treatment
(67)
Endometrial and Cervical Cancer Treatments
(53)
Cervical Cancer and HPV Research
(29)
Cancer Immunotherapy and Biomarkers
(23)
Cancer Genomics and Diagnostics
(17)
Affiliations
Inova Health System
Gynecologic Oncology Group
Leiden University
Mayo Clinic
University of Arizona